Orphanet is a comprehensive online resource dedicated to gathering and providing information on rare diseases and orphan drugs. Established in France in 1997 at the advent of the internet, its primary goal is to improve the diagnosis, care, and treatment of individuals living with rare diseases. It maintains a database of rare diseases, including [...]
The challenge of diagnosing rare muscle diseases Imagine visiting a doctor for unexplained difficulty of walking only to be told that, despite advanced genetic testing, the cause remains unknown. This is the reality for many patients with rare neuromuscular diseases (NMDs) - a group of conditions affecting the muscles and nerves. Scientists have linked [...]
Neuromuscular diseases (NMDs) encompass a wide range of disorders that can affect the muscles and the nerves controlling them. From Duchenne muscular dystrophy to spinal muscular atrophy (SMA), these diseases present significant challenges for patients and their families, especially in understanding the underlying causes, disease progression, and available treatment options. One crucial element of [...]
Understanding muscular dystrophy through AI and genetics The power of precision medicine in neuromuscular disorders Muscular dystrophy is a complex group of genetic disorders that progressively weaken muscles, affecting mobility and quality of life. Traditional methods of diagnosing and categorizing these conditions rely on symptoms and genetic testing, but a new frontier is emerging. [...]
The Italian patient association ACMT-Rete per la Malattia di Charcot-Marie-Tooth published an article about our project CoMPaSS-NMD. Even with advanced tools for diagnosing neuromuscular diseases like Charcot-Marie-Tooth, many patients still don't get a clear diagnosis. This is a major hurdle for clinical trials. They are supporting our European project CoMPaSSNMD which will help speed up [...]
Congratulations to Joanna Polanska from Politechnika Śląska! We're thrilled that our AI & tech expert has been accepted as a member of the International Rare Diseases Research Consortium (IRDiRC) Diagnostic Scientific Committee. The IRDiRC DSC is a prestigious committee dedicated to accelerating rare disease diagnosis and research, ensuring all patients with suspected rare diseases [...]
What can our genetic background reveal? Unlocking new possibilities for neuromuscular disorder care through CoMPaSS-NMD approach. Our genetic background acts as an "instruction manual" for how we develop, function, and express various traits, including susceptibility to diseases, physical features, and even behaviors. For patients with neuromuscular disorders, this genetic diversity plays a crucial role [...]
Your health, our CoMPaSS: Welcome to the CoMPaSS-NMD Newsletter! We are thrilled to launch the first issue of our project newsletter, keeping you informed about the exciting progress of CoMPaSS-NMD (Computational Models for new Patients Stratification Strategies of Neuromuscular Disorders). In this issue: 1. A project overview Our objectives: Faster and more accurate diagnoses [...]
What do the 2024 Nobel Prizes in Physics and Chemistry have in common with the CoMPaSS-NMD Project? Two words: Artificial Intelligence (AI). "For fundamental discoveries and inventions that have made machine learning possible with artificial neural networks". This is the official recognition given to the 2024 Nobel Prize in Physics, jointly awarded to John [...]
The CoMPaSS-NMD project is at the forefront of developing innovative computational approaches to revolutionize patient stratification in neuromuscular disorders (NMDs). To support this mission, the Young Investigator Training (YIT) initiative was established to foster the growth of young researchers in the field. The YIT Initiative: the 2024 summer edition The YIT 1 program, from [...]